Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Last updated on July 2021Recruitment
- Recruitment Status
- Terminated
- Estimated Enrollment
- 36
Summary
- Conditions
- Pneumonia
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01532544
- Collaborators
- Anders Perner
- Rigshospitalet, Denmark
- Investigators
- Not Provided